Defining and Characterizing the Progression of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is a progressive disease in which the risks of myocardial infarction, stroke, microvascular events, and mortality are all strongly associated with hyperglycemia (1). The disease course is primarily characterized by a decline in �-cell function and worsening of insulin resistance. The process is manifested clinically by deteriorations in multiple parameters, including A1C, fasting plasma glucose (FPG), and postprandial glucose levels. In this review, we will evaluate our current understanding of the role played by deteriorating �-cell function and other abnormalities linked with the progression of type 2 diabetes. An improved understanding of these abnormalities may provide the scientific groundwork for novel therapies that may help achieve and maintain good glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Moreover, the essential oil extracted from CW, primarily comprising esters (58.3%) and ketones (33.5%), has also demonstrated notable free radical scavenging activity and antioxidant potential [49].”
From Research Progress in Coconut Water: A Review of Nutritional Composition, Biological Activities, and Novel Processing Technologies (2025) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Regardless of the treatment regime, longitudinal studies in humans have demonstrated that beta-cell function generally deteriorates over time.49,50”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Following the induction of insulin resistance, islet beta-cells can maintain normoglycaemia and metabolic homeostasis by increasing their secretion of insulin and/or by increasing their number.49,96,97”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“The gradual decline in islet beta-cell number and function results in insulin levels becoming too low to promote metabolic homeostasis and T2D results.49,91”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
In the citing paper
“Obesity has been estimated to induce an ~50% increase in islet beta-cell volume due to increased neogenesis.49”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [49]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 301–400 of 574
Defining Disease Progression and Drug Durability in Type 2 Diabetes Mellitus
Kalra, S., Kamaruddin, N. A., Visvanathan, J., & Santani, R. (2019) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2019.15.2.67 · Cited by 11
Sharafi, M., Mohsenpour, M. A., Afrashteh, S., Eftekhari, M. H., Dehghan, A., Farhadi, A., Jafarnezhad, A., Zakeri, A., & Looha, M. A. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02648-3 · Cited by 9
Bjarkø, V. V., Haug, E. B., Langhammer, A., Ruiz, P. L., Carlsson, S., Birkeland, K. I., Berg, T. J., Sørgjerd, E. P., Lyssenko, V., & Åsvold, B. O. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004493 · Cited by 11
Mitchell, A. J., Fall, T., Melhus, H., Lind, L., Michaëlsson, K., & Byberg, L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab490 · Cited by 8
Barham, A., Mohammad, B. A., Hasoun, L., Awwad, S. H., Mosleh, I. M., Aljaberi, A., & Abu‐Samak, M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14779 · Cited by 9
Xu, R., Zheng, T., Ouyang, C., Ding, X., & Ge, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1110523 · Cited by 10
Carretero, R. G., Gómez, O. V., Gil-Prieto, R., & de Miguel, Á. G. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02278-1 · Cited by 8
Ajjan, R., Seidu, S., & Riveline, J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01607-5 · Cited by 9
Iraj, B., Taheri, N., Amini, M., Amini, P., & Aminorroaya, A. (2010) · PubMed Central · Cited by 8
Diabetic Retinopathy and Diabetic Macular Edema in People With Early-Onset Diabetes
Reddy, N. G., Venkatesh, R., Jayadev, C., Gadde, S. G. K., Agrawal, S., Mishra, P., Yadav, N. K., & Chhablani, J. K. (2022) · Clinical Diabetes · doi:10.2337/cd21-0110 · Cited by 8
Martiskainen, T., Lamidi, M., Venojärvi, M., Tikkanen, H. O., & Laatikainen, T. K. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058546 · Cited by 16
Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats
Vargas‐Guerrero, B., López, P. M. G., Santiago, A. E. G., Domínguez-Rosales, J. A., & Gurrola‐Díaz, C. M. (2013) · Biological Research · doi:10.4067/s0716-97602013000300009 · Cited by 10
Peyrot, M. F., Skovlund, S. E., Radzio, R., & Kokoszka, A. (2019) · Clinical Diabetology · doi:10.5603/dk.2019.0012 · Cited by 10
Franch‐Nadal, J., Mata‐Cases, M., Ortega, E., Real, J., Gratacòs, M., Vlacho, B., Vallés, J. A., & Mauricio, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091389 · Cited by 8
Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetes
Engelbrechtsen, L., Galijatovic, E. A. A., Roepstorff, S., Hansen, T. F., & Vestergaard, H. (2015) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000160 · Cited by 8
Ishola, A. F., Gerstein, H. C., Engert, J. C., Mohan, V., Díaz, R., Anand, S. S., & Meyre, D. (2016) · Scientific Reports · doi:10.1038/srep30744 · Cited by 8
Chaufan, C., Fielding, H., Chesla, C. A., & Fernández, A. (2015) · Emerald Group Publishing Limited eBooks · doi:10.1108/s0275-495920150000033013 · Cited by 7
Legaard, G. E., Lyngbæk, M. P. P., Almdal, T., Durrer, C. G., Nystrup, U., Larsen, E. L., Poulsen, H. E., Karstoft, K., Pedersen, B. K., & Ried‐Larsen, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.031 · Cited by 7
Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
Herold, M., Szász, A. M., Szentmártoni, G., Martinek, E., Madar-Dank, V., Barna, A. J., Mohácsi, R., Somogyi, A., Dank, M., & Herold, Z. (2023) · Scientific Reports · doi:10.1038/s41598-023-40216-3 · Cited by 10
Hong, J. H., Kim, M., Min, K. W., Won, J. C., Kim, T. N., Lee, B., Kang, J. G., Kim, J. H., Park, J. H., Ku, B. J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15985 · Cited by 11
The Kidney as a Treatment Target for Type 2 Diabetes
Dokken, B. B. (2012) · Diabetes Spectrum · doi:10.2337/diaspect.25.1.29 · Cited by 9
Schwartz, S. S., & Katz, A. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s65588 · Cited by 8
Glycaemic control in native Kuwaiti Arab patients with type 2 diabetes
Channanath, A. M., Al‐Wotayan, R., Alkandari, H., Davidsson, L., Tuomilehto, J., & Thanaraj, T. A. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.009 · Cited by 7
A review article- gestational diabetes mellitus
Sreelatha, S. (2019) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2019.07.00238 · Cited by 9
Hoffman, E. G., D’Souza, N. C., Aiken, J., ATHERLEY, S. C., Liggins, R., & Riddell, M. C. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15002 · Cited by 9
SGLT2 Inhibition: A Novel Prospective Strategy in Treatment of Diabetes Mellitus
Deshmukh, A. B., Patel, M. C., & Mishra, B. (2013) · Renal Failure · doi:10.3109/0886022x.2013.766560 · Cited by 8
Dariushnejad, H., Mohammadi, M., & Ghorbanzadeh, V. (2019) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2018_138 · Cited by 7
Muhammed, A. A., Taj, A., Ahmed, M. U., & Tabrez, E. S. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.3.57 · Cited by 7
Xhakaza, L., Abrahams-October, Z., Pearce, B., Masilela, C. M., Adeniyi, O. V., Johnson, R., Ongole, J. J., & Benjeddou, M. (2020) · Drug metabolism and drug interactions · doi:10.1515/dmpt-2020-0111 · Cited by 7
Kahn, H. S., Stein, A. D., & Lumey, L. H. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000474 · Cited by 11
Boye, K. S., Mody, R., Wu, J., Lage, M. J., Botros, F. T., & Woodward, B. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.07.002 · Cited by 7
Handley, D., Gillett, A. C., Bala, R., Tyrrell, J., & Lewis, C. M. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004826 · Cited by 10
Gonzalez-Flo, E., Kheirabadi, E., Rodríguez‐Caso, C., & Macía, J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1149698 · Cited by 6
Lee, E. Y., Cho, J., Lee, W. J., Kim, N. H., Kim, J. H., & Lee, B. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110884 · Cited by 6
Deora, N., Harishankar, N., Satyavani, M., Sunitha, M. M., Venkataraman, K., & Venkateshan, V. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118849 · Cited by 7
Shakiba, E., Pasdar, Y., Asoudeh, F., Najafi, F., Saber, A., Shakiba, M. H., & Bagheri, A. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01787-y · Cited by 7
Bae, J., Yu, M. H., Lee, M., Soo, B., & Lee, B. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2120 · Cited by 6
Patel, Y. R., Kirkman, M. S., Considine, R. V., Hannon, T. S., & Mather, K. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2056 · Cited by 6
Baker, J., Manirajan, A., Lewis, J., Seidel, H., & Strelzow, J. (2023) · JAAOS Global Research and Reviews · doi:10.5435/jaaosglobal-d-23-00043 · Cited by 6
Mefford, I. N., Mefford, J. T., & Burris, C. (2012) · Case Reports in Endocrinology · doi:10.1155/2012/468609 · Cited by 6
Perl, S., Cook, W., Wei, C., Öhman, P., & Hirshberg, B. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.10.006 · Cited by 7
Kawamoto, K., Anstrom, K. J., Anderson, J. B., Bosworth, H. B., Lobach, D. F., McAdam‐Marx, C., Ferranti, J. M., Shang, H., & Yarnall, K. S. H. (2016) · PubMed · Cited by 7
He, W., Xu, Q., Han, L., Wu, T., Shi, X., Ye, L., Yao, G., & Li, X. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00759-w · Cited by 7
Kishimoto, I., & Ohashi, A. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211018721 · Cited by 6
Prevalence of hyperglycemia in masters athletes
Climstein, M., Walsh, J., Adams, K., Sevene, T. G., Heazlewood, T., & DeBeliso, M. (2022) · PeerJ · doi:10.7717/peerj.13389 · Cited by 6
Martinez, Y. V., Campbell, S., Hann, M., & Bower, P. (2016) · Salud Pública de México · doi:10.21149/spm.v58i4.8020 · Cited by 6
Lifestyle Medicine: Why Do We Need It?
Pijl, H. (2018) · Medical Science Educator · doi:10.1007/s40670-018-00632-x · Cited by 8
Liu, S., Liu, J., Gurung, R. L., Chan, C., Yeo, D., Ang, K., Tang, W. E., Subramaniam, T., Sum, C. F., & Lim, S. C. (2019) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v48n7p217 · Cited by 6
Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
Паневин, Т. С., Zhelyabina, O. V., Елисеев, М. С., & Shestakova, M. V. (2020) · Diabetes Mellitus · doi:10.14341/dm12412 · Cited by 6
Duque, N., Artime, E., Romera, I., Lebrec, J., Díaz‐Cerezo, S., Rubio, M., Sicras‐Mainar, A., Carretero-Anibarro, E., Mundet, X., Martínez, J. J. G., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01773-z · Cited by 7
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
Aleppo, G., Carlson, A. L., McGill, J. B., Alshannaq, H. A., Galindo, R. J., Kruger, D. F., Levy, C. J., Matuoka, J. Y., Ilham, S., Umpierrez, G. E., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251414980 · Cited by 6
Kasujja, F. X., Aikaeli, F., Garrib, A. V., van Widenfelt, E., Namakoola, I., Kivuyo, S. L., Prior, J. A., Birungi, J., Moyo, F., Wang, D., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)02641-8 · Cited by 5
Antidiabetic Properties of Nymphaea Species (Water Lilies): A Review
Prodhan, A. H. M. S. U., & Mridu, F. S. (2022) · The Natural Products Journal · doi:10.2174/2210315512666220405083207 · Cited by 5
Choi, K. S., Hwang, I., Moon, J. H., & Kim, M. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231197273 · Cited by 5
Patel, N. S., Patel, B. H., & Kaushal, M. A. (2023) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2023.150510 · Cited by 5
McCarty, S. M., Clasby, M. C., & Sexton, J. Z. (2024) · Assay and Drug Development Technologies · doi:10.1089/adt.2023.119 · Cited by 6
Zainudin, A. M., Rasool, A. H. G., Yaacob, N. M., Muhamad, R., & Mohamed, W. M. I. W. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01577-6 · Cited by 5
Search for Novel Therapeutic Targets of Type 2 Diabetes Mellitus
Yadav, N. K., Mazumder, R., Rani, A., Kumar, A., & Kaur, J. (2024) · Current Drug Therapy · doi:10.2174/0115748855313087240719072514 · Cited by 5
Deethai, P., Siriwathanakul, C., Pitchakarn, P., Imsumran, A., Wongnoppavich, A., Dissook, S., & Chewonarin, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178176 · Cited by 6
Nuttall, F. Q., Almokayyad, R. M., & Gannon, M. C. (2020) · Physiological Reports · doi:10.14814/phy2.14569 · Cited by 6
Chang, H., Yang, Y.-H., Lo, C., & Huang, Y. (2022) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000977 · Cited by 6
Heitaku, S., Sasase, T., Sotani, T., Maki, M., Katsumi, S., Fukuda, S., Goto, H., Yamamoto, H., & Nishiu, J. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00129 · Cited by 7
Ajayi, I. O., Balogun, W., Olopade, O. B., Ajani, G. O., Soyoye, D. O., Bolarinwa, O. A., Olamoyegun, M. A., Alatishe-Muhammad, B. W., Odeniyi, I. A., Odukoya, O. O., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1192491 · Cited by 9
Christofides, E. A., Puente, O. A., Norwood, P. C., Denham, D. S., Maheshwari, H., Lillestol, M. J., Hart, T., Nakhle, S., Chadha, A., Fitzpatrick, D., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15560 · Cited by 5
Clinical and cost–effectiveness of insulin degludec: from clinical trials to clinical practice
Evans, M., & McEwan, P. C. (2015) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.15.10 · Cited by 5
Menon, A., Gray, L., Fatehi, F., Bird, D., Darssan, D., Karunanithi, M., & Russell, A. W. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819836647 · Cited by 9
Jensen, A. D., Andersen, S. T., Charles, M., Bjerg, L., Witte, D. R., Gram, B., Jørgensen, M. E., Sandbæk, A., & Dalsgaard, E. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.09.001 · Cited by 5
Artificial Intelligence for Iris-Based Diagnosis in Healthcare
Agarwal, R., Samant, P., Bansal, A., & Agarwal, R. (2023) · Springer eBooks · doi:10.1007/978-981-19-1550-5_106-1 · Cited by 5
Mathieu, C., Catrinoiu, D., Ranetti, A.-E., JOHNSSON, E. K., Hansen, L., Chen, H., García‐Sánchez, R., Iqbal, N., & Celiñski, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0445-x · Cited by 5
Chung, J. O., Park, S., Cho, D. H., Chung, D. J., & Chung, M. Y. (2018) · Medicine · doi:10.1097/md.0000000000011783 · Cited by 5
Management of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Cui, H., Zhao, C.-Y., Lv, Y., Wei, M., Zhu, Y., Ma, X., Xia, Y.-H., Tian, J., Ma, Y., Liu, Y., et al. (2021) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-020-00665-x · Cited by 5
Galdo, J. A., Thurston, M. M., & Bourg, C. A. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.2.66 · Cited by 5
Jeong, M., McColl, T. J., & Clarke, D. C. (2025) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2025-0017 · Cited by 5
Gama, F. D. S., Ferreira, M. A., Segretti, N., Damião, M. C. F. C. B., Guimarães, C. R. W., Mascarello, A., & de Azevedo, H. F. Z. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02225 · Cited by 4
Rohde, C., Thomsen, R. W., & Østergaard, S. D. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001508 · Cited by 4
Romano, I., & Serra, R. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01489-z · Cited by 5
Lessons learned from a peer-supported diabetes education program in two dissimilar Mayan communities
Hernández, K. G. C., Espinosa, A., Molina-Seguí, F., Ayuso-Peraza, G., Mena-Macossay, L., Méndez‐Domínguez, N., Bastarrachea, R. A., & Laviada‐Molina, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280539 · Cited by 4
Gomes, C. B., Ramos, J. S., Silveira-Rodrigues, J. G., Leite, D. M. D. M., Melo, B. P., & Soares, D. D. (2024) · Experimental Brain Research · doi:10.1007/s00221-024-06795-x · Cited by 4
Hernández-Martín, M., Bocanegra, A., Garcimartín, A., Issa, J. Á., Redondo‐Castillejo, R., Macho‐González, A., Benedí, J., Sánchez-Muniz, F. J., & López‐Oliva, M. E. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.02.010 · Cited by 4
Common mistakes concerning diabetes management in daily clinical practice
Makrilakis, K., & Papachristoforou, E. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.09.004 · Cited by 6
Chew, B., Lee, P. Y., Cheong, A. T., Ismail, M., Bujang, M. A., Haniff, J., Taher, S. W., & Goh, P. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0298-z · Cited by 4
Lin, S.-D., Su, S., Wang, S.-Y., Tu, S., & Hsu, S.-R. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.03.002 · Cited by 5
Boye, K. S., Lage, M. J., & Kiljanski, J. I. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01051-9 · Cited by 5
Gestational Diabetes Mellitus: A Narrative Review
Ali, A. I., & Nori, W. (2021) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1_21 · Cited by 5
Sun, H., Xu, L., Liu, L., Zhan, S., Wang, S., & Song, Y. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07731-x · Cited by 5
Popp, D., Aertsen, S., Daldrup, C. L., Coppenrath, E., Hetterich, H., Saam, T., Rottenkolber, M., Seißler, J., Lechner, A., & Sommer, N. N. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00187 · Cited by 6
Torre, C., Guerreiro, J., Longo, P., Raposo, J. F., Leufkens, H. G. M., & Martins, A. P. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s170134 · Cited by 4
Xhakaza, L., Abrahams-October, Z., Pearce, B., Masilela, C. M., Adeniyi, O. V., Johnson, R., Ongole, J. J., & Benjeddou, M. (2020) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmdi-2020-0111 · Cited by 6
Davis, J. W., Lim, E., Taira, D. A., & Chen, J. (2020) · Medical Care · doi:10.1097/mlr.0000000000001378 · Cited by 4
Hertzman-Miller, R. P., Beverly, E. A., & Goodrich, A. M. (2014) · Journal of Continuing Education in the Health Professions · doi:10.1002/chp.21223 · Cited by 4
Dapagliflozin combination therapy in type 2 diabetes mellitus
Yacoub, T. G. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2016.1111119 · Cited by 6
Jang, H. N., Yang, Y., Oh, T. J., Koo, B. K., Lee, S. O., Park, K. S., Jang, H. C., & Jung, H. S. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13634 · Cited by 4
Coppell, K. J., Lee, J. S., Williams, S., & Mann, J. I. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.04.021 · Cited by 4
Sohouli, M. H., Tavakoli, S., Reis, M. G., Hekmatdoost, A., & Guimarães, N. S. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00812-0 · Cited by 4
Brai, B. I. C., Joseph, R. O., Komolafe, T. R., Amosun, B. E., Crown, O. O., Komolafe, K., & Ogungbe, I. V. (2024) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2024.2426497 · Cited by 2
Obirikorang, C., Adu, E. A., Awuah, A. A.-A., Darko, S. N., Ghartey, F. N., Ametepe, S., Nyarko, E. N. Y., Anto, E. O., & Owiredu, W. K. B. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0302912 · Cited by 4
Huang, X., He, S., Wang, C., Jian, G., Jiang, K., Lu, Z., Wang, W., Sheng, G., & Zou, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1500993 · Cited by 3
Larsen, A. T., Melander, S. A., Mohamed, K. E., Petersen, E. A., Benmarce, M., Karsdal, M. A., & Henriksen, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118388 · Cited by 3
Ho, V., Tran, T., Patel, J., Teshome, B., & Rai, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412032 · Cited by 3
Metadata
- Authors
- Fonseca, V. A.
- Affiliations
- Tulane University (US)
- Corresponding author
- Fonseca, Vivian A.
- ORCID
- Fonseca, Vivian A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S151-S156
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811457
- OpenAlex
- W2128050336
- Cited by
- 573
- References
- 40
- Citations by year
- 2026: 29 · 2025: 28 · 2024: 50 · 2023: 51 · 2022: 41 · 2021: 51 · 2020: 54 · 2019: 50 · 2018: 43 · 2017: 37 · 2016: 43 · 2015: 37 · 2014: 23 · 2013: 17 · 2012: 7
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes progression, beta-cell function decline, insulin resistance, hyperglycemia, glycemic control, HbA1c, fasting blood glucose, postprandial blood glucose, microvascular complications, cardiovascular risk
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Insulin Resistance, Obesity, Prediabetic State, Weight Gain, Disease Progression, Postprandial Period, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.